English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The European Society of Cardiology (ESC) Guidelines recommend Dual Antiplatelet Therapy (DAPT) using aspirin and a P2Y12 receptor inhibitor for 6 months, following an Acute Coronary Syndrome (ACS) with coronary stent implantation. However, when a patient is on DAPT and needs urgent surgery within these 6 months, DAPT raises issues. Interruption of a P2Y12 receptor inhibitor is recommended for 3-7 days prior to surgery to enable recovery of platelet function and eliminate the potential risk of periand post-procedural bleeding. On the other hand, early cessation of antiplatelet therapy has been related with cardiac ischaemic complications and these patients are considered as being at high ischaemic risk [1 4].

Bridging with Tirofiban During Temporary Withdrawal of Oral Antiplatelets for Two Major Surgical Procedures in High Ischaemic Risk Patients